
VARIANTS IN MITOCHONDRIAL tRNA GENE MAY NOT
BE ASSOCIATED WITH THYROID CARCINOMA Lv F1,a, Qian G2,a, You W1,a, Lin H3, Wang XF3, Qiu GS2,
Jiang YS2, Pang LX3, Kang YM4, Jia BF4, Xu JZ5,*, Yu Y1,* *Corresponding Author: Dr. Jinzhong Xu, Department of Clinical Pharmacy, the Affiliated Wenling Hospital
of Wenzhou Medial University, Taiping Nan Road 190, Wenling 317500, People’s Republic of China. Tel./Fax:
+86-(0)576-8620-6288. E-mail: xujzwl@163.com and Dr. Yang Yu, Department of Breast Surgery, Henan Provincial
People’s Hospital, Weiwu Road 7, Zhengzhou 450003, People’s Republic of China. Tel./Fax: +86-(0)371-
6558-0014. E-mail: 510790135@qq.com page: 59
|
MATERIALS AND METHODS
Database Searches. We systematically searched
for unrestricted language articles included in PubMed,
Embase, Google Scholar, Cochrane Library, China
National Knowledge Infrastructure (CNKI), Chinese
VIP, and Chinese Wan-fang databases from inception
to December 2015. The literature search in PubMed
was carried out using the following keywords “mitochondrial
tRNA mutations, thyroid carcinoma,” or
“mt-tRNA mutations, thyroid cancer,” or “mt-tRNA
variants, thyroid cancer.” We excluded studies if the
crucial data were not reported in original papers,
or if they had a very high probability of inaccurate
reporting.
Data Extraction. Data were independently
extracted by two authors (F. Lv and G. Qian), and
checked by another author (W. You). Any disagreement
was resolved by discussions until consensus
was reached.
Determining the Conservation Index of These
mt-tRNA Variants. With the purpose of understanding
the possible role of mt-tRNA variants in thyroid
cancer, we performed a phylogentic approach to see
the conservation index (CI) of each mt-tRNA variant.
In brief, the mtDNA sequences of 15 vertebrates
were used in the inter-specific analyses; these species
included Mus musculus, Gorilla gorilla, Hylobates
lar, Lemur catta, Pan paniscus, Homo sapiens, Thylamys
elegans, Procavia capensis, Cavia porcellus,
Orycteropus afer, Bos taurus, Sus scrofa, Felis catus,
Platanista minor and Herpestes javanicus. The CI
was then calculated by comparing the human nucleotide
(nt) variants with 14 other vertebrates. Notably,
the CI of >70.0% was regarded to have a functional
potential [10].
Calculation of the ⊿G of mt-tRNA With and
Without These Variants. To see whether these variants
affected the ⊿G of mt-tRNAs, we used the RNA
Fold Web server program to measure the ⊿G of each
mt-tRNA with and without these variants (http://rna.
tbi.univie.ac.at/cgi-bin/ RNAfold. cgi) [11].
Screening for the Frequency of the A12308G
Variant in Thyroid Carcinoma. We then performed
the polymerase chain reaction (PCR)-Sanger sequence
to detect the occurrence of the “well-known”
A12308G variant in patients with thyroid cancer.
Briefly, a total of 300 blood samples of thyroid cancer
(150 male and 150 females; average age 52 years)
and 200 healthy subjects (100 males and 100 females;
average age 49 years) were recruited from the Henan
Provincial People’s Hospital, Zhengzhou, People’s
Republic of China (PRC). Informed consent and
clinical evaluation were obtained from all these subjects.
The study protocol was approved by the Ethics
Committee of Henan Provincial People’s Hospital.
We first extracted the genomic DNA from each
sample, then we used the PCR to amplify the gene using
the following primer sequences: forward (5’-TGC
TAG TAA CCA CGT TCT CC-3’); reverse (5’-TTT
GTT AGG GTT AAC GAG GG-3’). The PCR product
was subsequently examined for specificity using
1.5% agarose gel electrophoresis. Double-stranded
automated sequencing was performed using an ABI
PRISM™ 3700 sequencing machine (Applied Biosystems
Inc., Foster City, CA, USA). The sequence
was then compared with the human mitochondrial
reference sequence (NC_012920) [6].
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|